Cargando…
Will Patients With Liver Metastasis From Aggressives Cancers Benefit From Surgical Resection?
BACKGROUND: We aimed to evaluate the outcomes of resections for liver metastases (LMs) originating from pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), and esophagus/gastric cancers (EGCs), which we label as major killers (MKs; overall survival (OS) under 10%). We hypoth...
Autores principales: | Al Farai, Abdallah, Garnier, Jonathan, Palen, Anais, Ewald, Jacques, Delpero, Jean-Robert, Turrini, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822689/ https://www.ncbi.nlm.nih.gov/pubmed/36660208 http://dx.doi.org/10.14740/wjon1516 |
Ejemplares similares
-
Prospective Evaluation of Resection Margins Using Standardized Specimen Protocol Analysis among Patients with Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
por: Garnier, Jonathan, et al.
Publicado: (2021) -
Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy
por: Garnier, Jonathan, et al.
Publicado: (2023) -
Is percutaneous destruction of a solitary liver colorectal metastasis as effective as a resection?
por: Marchese, Ugo, et al.
Publicado: (2021) -
Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study
por: Garnier, Jonathan, et al.
Publicado: (2020) -
Peak Risk of Recurrence Occurs during the First Two Years after a Pancreatectomy in Patients Receiving Neoadjuvant FOLFIRINOX
por: Alfano, Marie-Sophie, et al.
Publicado: (2023)